ArticleJACC. Case reports2026
Transcatheter Closure of Aortic Paravalvular Leak After the Ozaki Procedure.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAortic valve disease requires individualized treatment strategies. The Ozaki procedure is an alternative to valve replacement; however, paravalvular leak (PVL) remains a potential complication. CASE SUMMARY: A 62-year-old man with previous Ozaki procedure presented with NYHA functional class III dyspnea. Echocardiography revealed moderate-to-severe PVL between the right and noncoronary cusps. Because of high surgical risk (Society of Thoracic Surgeons score 9.1%), transcatheter closure was performed under transesophageal echocardiography guidance using a 5 × 4-mm Amplatzer Duct Occluder II via transfemoral access. The device was successfully deployed with trivial residual regurgitation. The patient was discharged in stable condition with clinical improvement at 6 months. DISCUSSION: This case demonstrates the feasibility and safety of transcatheter PVL closure after the Ozaki procedure, particularly in high-risk patients, highlighting its potential as a minimally invasive alternative. TAKE-HOME MESSAGES: Transcatheter PVL closure appears to be a safe and effective treatment choice after the Ozaki procedure. Careful imaging guidance is essential for optimal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.